PanGen Biotech Inc. (KOSDAQ:222110)
6,180.00
+130.00 (2.15%)
Last updated: Aug 6, 2025
Achilles Therapeutics Market Cap
PanGen Biotech has a market cap or net worth of 83.93 billion as of August 8, 2025. Its market cap has increased by 47.95% in one year.
Market Cap
83.93B
Enterprise Value
73.73B
Revenue
14.64B
Ranking
n/a
PE Ratio
45.82
Stock Price
$6,180.00
Market Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 83.93B, a decrease of -51.00%. That is a compound annual growth rate of -7.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 83.93B | 14.17% |
Dec 30, 2024 | 73.52B | 0.08% |
Dec 28, 2023 | 73.46B | 5.85% |
Dec 29, 2022 | 69.40B | -30.44% |
Dec 30, 2021 | 99.78B | 1.96% |
Dec 30, 2020 | 97.86B | 30.63% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Mar 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 460.93T |
SK hynix | 177.07T |
LG Energy Solution | 88.57T |
Samsung Biologics | 73.24T |
Hyundai Motor Company | 46.44T |
Hanwha Aerospace | 45.33T |
Doosan Enerbility | 42.53T |
HD Hyundai Heavy Industries | 41.41T |